Access to Health Foundation
Agility Holdings Group which invests in innovative InsurTech and HealthTech
Based in TX
🤖
AI Overview
With $200K in lobbying spend across 5 quarterly filings, Access to Health Foundation is an active lobbying client. Their lobbying covers 2 issue areas.
$200K
Total Spend
1
Years Active
1
Firms Hired
4
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
- •Provide government relations services and function as Agility's lobbyists on issues related to insurance coverage, Medicare Advantage, Medicaid, IRA, ACA, as well as rural healthcare access, health an
- •Issues related to insurance coverage, Medicare Advantage, Medicaid, IRA, ACA, as well as rural healthcare access, health and wellness and the MAHA movement.
- •Issues related to insurance coverage, Medicare Advantage, Medicaid, IRA, ACA, as well as rural healthcare access, health and wellness and the MAHA movement. H.R. 1, "One Big Beautiful Bill Act".
- •Issues related to individual insurance coverage, ACA premium subsidies, rural healthcare access, and health and wellness in the MAHA movement.
- •Medicare Advantage, Medicaid coverage issues, IRA implementation.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.